Back to Results
First PageMeta Content
Chemistry / Rare diseases / Biochemistry / Lactams / Sirolimus / Lymphangioleiomyomatosis / Everolimus / Mammalian target of rapamycin / Osteoprotegerin / Macrolides / Immunosuppressants / Biology


LAM  in  the  News July  2013 TSC2/TSC1  Field: Mol  Endocrinol.  2013  Jul  2.  [Epub  ahead  of  print] Uterine-­‐Speci+ic  loss  of  Tsc2  leads  to  myometr
Add to Reading List

Document Date: 2013-08-01 12:47:33

Open Document

File Size: 151,85 KB

Share Result on Facebook

City

Rochester / /

Country

United States / /

Facility

University of Rochester Medical Center / /

IndustryTerm

important research tool / /

MedicalCondition

lymphangioleiomyomas / Lymphangioleiomyomatosis / leiomyomas / tumor / benign tumors / abdominal lymphangioleiomyoma / uterine leiomyomas / null myometrial tumors / rare disease / lymphatic abnormalities / lymphangioleiomyoma and chylous ascites / both diseases / sporadic lymphangioleiomyomatosis / myometrial tumors / /

Organization

University of Rochester / United States Food and Drug Administration / /

ProvinceOrState

New York / /

Technology

pharmacokinetics / drug discovery / /

URL

http /

SocialTag